<DOC>
	<DOCNO>NCT01559207</DOCNO>
	<brief_summary>The main objective study evaluate , 15 healthy volunteer 15 patient history venous thromboembolism ( VTE ) , monthly variation ( 6 month ) plasma nucleosome free DNA concentration .</brief_summary>
	<brief_title>Reproducibility Plasma Nucleosomes Free DNA Markers Venous Thromboembolism</brief_title>
	<detailed_description>The secondary objective study : A . To describe , 15 healthy volunteer history venous thromboembolism ( VTE ) , plasma nucleosome DNA concentration . B . To describe , 100 patient history VTE currently consult chronic disease thrombophilia work-up , plasma nucleosome DNA concentration . C. To compare plasma nucleosome DNA concentration healthy volunteer VTE patient D. To describe , 100 patient history VTE currently consult chronic disease thrombophilia work-up , relationship classification VTE plasma nucleosome concentration : - anatomical classification VTE : ( ) superficial , deep ( ( ii ) distal ( iii ) proximal ) , ( iv ) pulmonary embolism - circumstantial classification VTE : ( ) trigger , chronic risk factor ; ( ii ) untriggered , chronic risk factor ; ( iii ) trigger , chronic risk factor ; ( iv ) untriggered , chronic risk factor ( idiopathic ) E. To describe , 100 patient history VTE , variation plasma nucleosome concentration 6 month first evaluation - accord anatomical classification - accord circumstantial classification - accord intercurrent event treatment F. To compare plasma concentration nucleosomes free DNA G. To evaluate relationship plasma nucleosome free DNA concentration : - circulate leukocyte population : total leukocyte count , absolute number neutrophil , monocyte , lymphocytes - marker coagulation activation : d-dimers , circulate fibrin monomer - platelet count - patient antivitamin K : INR , patient receive heparin : antiXa activity H. Creation biological collection</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<criteria>The patient volunteer must give his/her inform sign consent The patient volunteer must insure beneficiary health insurance plan The patient volunteer available 6 month followup For group `` P '' : patient history VTE For group `` T '' : healthy volunteer history VTE history chronic disease history neoplastic disease history chronic infection take anticoagulant , antiplatelet medication acute disease infection last 2 week The patient participate another study The patient exclusion period determine previous study The patient judicial protection , tutorship curatorship The patient refuse sign consent It impossible correctly inform patient The patient pregnant , parturient , breastfeed The patient give birth past three month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>nucleosome</keyword>
	<keyword>plasma nucleosome concentration</keyword>
	<keyword>free DNA</keyword>
	<keyword>plasma free DNA concentration</keyword>
</DOC>